Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

2.51
Delayed Data
As of Apr 20
 -0.03 / -1.18%
Today’s Change
1.62
Today|||52-Week Range
4.51
-35.81%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$277.9M

Company Description

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder. The company was founded by McEnany J. Patrick and Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL.

Contact Information

Catalyst Pharmaceuticals, Inc.
355 Alhambra Circle
Coral Gables Florida 33134
P:(305) 529-2522
Investor Relations:

Employees

Shareholders

Other institutional43.91%
Individual stakeholders15.28%
Mutual fund holders11.14%

Top Executives

Patrick J. McEnanyChairman, President & Chief Executive Officer
Steven R. MillerChief Operating & Scientific Officer
Alicia GrandeChief Financial Officer, Treasurer & VP
Gary IngenitoChief Medical Officer & Head-Regulatory Affairs
Brian ElsberndSenior Vice President-Legal & Compliance